Par Drugs & Chemicals Ltd

Par Drugs & Che. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Par Drugs & Chemicals Ltd

₹ 294 4.50%
22 Nov - close price
pardrugs.com NSE: PAR
About

Incorporated in 1982, Par Drugs & Chemicals Ltd manufactures APIs and Fine Chemicals[1]

Key Points

Business Overview:[1]
PACL manufactures Active Pharma Ingredients for domestic and exports markets, they have a portfolio of 15 APIs and 10 Fine Chemicals. It produces the entire range of products in the Antacid Molecules segment

Website NSE
  • Market Cap ₹ 362 Cr.
  • Current Price ₹ 294
  • High / Low ₹ 325 / 190
  • Stock P/E 19.8
  • Book Value ₹ 78.6
  • Dividend Yield 0.00 %
  • ROCE 25.0 %
  • ROE 18.5 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Debtor days have improved from 68.9 to 52.3 days.
  • Company's working capital requirements have reduced from 50.4 days to 40.2 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
19.59 16.92 22.08 23.51 24.82 22.93 24.49 22.93 25.89 24.00 22.82 22.61 34.66
15.55 13.36 17.56 19.81 18.92 19.70 19.10 18.79 18.53 18.77 16.72 18.37 23.25
Operating Profit 4.04 3.56 4.52 3.70 5.90 3.23 5.39 4.14 7.36 5.23 6.10 4.24 11.41
OPM % 20.62% 21.04% 20.47% 15.74% 23.77% 14.09% 22.01% 18.05% 28.43% 21.79% 26.73% 18.75% 32.92%
0.03 0.05 0.07 0.15 0.02 0.04 0.03 0.01 0.05 0.23 -0.05 0.07 1.02
Interest 0.23 0.10 0.09 0.05 0.03 0.03 0.03 0.02 0.03 0.02 0.05 0.02 0.03
Depreciation 0.83 0.77 0.87 0.73 0.91 0.74 0.85 0.83 0.85 0.87 0.89 0.90 0.91
Profit before tax 3.01 2.74 3.63 3.07 4.98 2.50 4.54 3.30 6.53 4.57 5.11 3.39 11.49
Tax % 26.25% 22.63% 33.06% 25.08% 25.10% 25.20% 24.01% 25.15% 25.27% 25.16% 27.20% 25.07% 25.15%
2.22 2.12 2.42 2.29 3.73 1.87 3.45 2.47 4.89 3.42 3.72 2.53 8.60
EPS in Rs 1.80 1.72 1.97 1.86 3.03 1.52 2.80 2.01 3.97 2.78 3.02 2.06 6.99
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
19 27 33 33 49 42 46 56 61 75 96 96 104
15 20 26 26 40 34 38 46 45 59 78 73 77
Operating Profit 3 7 7 7 8 8 8 9 16 16 18 23 27
OPM % 18% 27% 22% 22% 17% 19% 18% 17% 26% 22% 19% 24% 26%
0 0 0 0 0 0 0 0 2 0 0 0 1
Interest 1 4 4 4 2 2 2 1 1 0 0 0 0
Depreciation 1 2 2 3 3 3 3 3 3 3 3 3 4
Profit before tax 2 1 1 1 3 3 3 6 15 13 15 20 25
Tax % 34% 40% 27% 58% 42% 42% 24% 21% 21% 27% 25% 26%
1 1 1 0 2 2 3 5 12 9 11 14 18
EPS in Rs 2.07 1.33 1.65 0.78 3.43 2.78 2.79 3.87 9.44 7.49 9.21 11.78 14.85
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 32% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 13%
5 Years: 16%
3 Years: 16%
TTM: 8%
Compounded Profit Growth
10 Years: 35%
5 Years: 42%
3 Years: 13%
TTM: 44%
Stock Price CAGR
10 Years: %
5 Years: 66%
3 Years: 15%
1 Year: 28%
Return on Equity
10 Years: 16%
5 Years: 18%
3 Years: 17%
Last Year: 18%

Balance Sheet

Figures in Rs. Crores

Mar 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 3 3 3 3 3 3 4 6 6 12 12 12 12
Reserves 6 8 9 9 11 12 25 34 46 48 59 73 84
16 44 38 36 31 29 12 6 8 0 0 0 0
4 7 9 10 12 10 11 13 16 19 18 16 19
Total Liabilities 29 61 59 58 56 54 51 60 76 79 89 102 116
14 47 45 43 42 39 36 34 30 34 38 41 40
CWIP 6 0 0 0 0 0 0 1 5 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0 26
9 14 13 15 14 15 15 25 42 44 50 60 50
Total Assets 29 61 59 58 56 54 51 60 76 79 89 102 116

Cash Flows

Figures in Rs. Crores

Mar 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1 5 9 7 9 4 2 8 12 8 13 20
-7 -6 -0 -0 -2 -1 -0 -1 0 -3 -7 -6
6 2 -9 -5 -8 -4 -2 1 2 -10 0 0
Net Cash Flow 0 1 -1 1 -1 0 -0 7 14 -5 6 14

Ratios

Figures in Rs. Crores

Mar 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 67 104 83 81 61 75 67 81 75 90 65 52
Inventory Days 129 111 158 69 83 81 45 50 60 49 45
Days Payable 171 184 183 135 107 94 96 112 135 73 58
Cash Conversion Cycle 67 62 10 57 -5 51 55 30 13 14 40 40
Working Capital Days 114 102 61 66 -4 18 47 39 44 61 50 40
ROCE % 12% 10% 9% 12% 11% 12% 16% 25% 22% 23% 25%

Shareholding Pattern

Numbers in percentages

22 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
73.98% 74.21% 74.21% 74.21% 74.21% 74.21% 74.21% 74.21% 74.21% 74.21% 74.21% 73.37%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.07% 0.07% 0.32% 0.09%
0.00% 0.05% 0.12% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.05% 0.00% 0.00%
26.02% 25.75% 25.68% 25.79% 25.79% 25.79% 25.79% 25.79% 25.73% 25.68% 25.47% 26.54%
No. of Shareholders 3,5144,0344,2625,0715,6765,5855,6865,9027,0207,4038,0228,757

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls

  • Jun 2023
    Transcript
    Notes
    PPT
  • Jun 2023
    Transcript
    Notes
    PPT
  • Mar 2023
    Transcript
    Notes
    PPT
  • Mar 2023
    Transcript
    Notes
    PPT
  • Feb 2023
    Transcript
    Notes
    PPT
  • Nov 2022
    Transcript
    Notes
    PPT
  • Nov 2022
    Transcript
    Notes
    PPT
  • Aug 2022
    Transcript
    Notes
    PPT
  • May 2022
    Transcript
    Notes
    PPT
  • Feb 2022
    Transcript
    Notes
    PPT
  • Dec 2021
    Transcript
    Notes
    PPT
  • Nov 2021
    Transcript
    Notes
    PPT
  • Jun 2021
    Transcript
    Notes
    PPT
  • Nov 2020
    Transcript
    Notes
    PPT
  • Nov 2020
    Transcript
    Notes
    PPT
  • Jun 2020
    Transcript
    Notes
    PPT
  • Sep 2019
    Transcript
    Notes
    PPT